87 related articles for article (PubMed ID: 8703667)
1. The effect of HN-65021 on responses to angiotensin II in human forearm vasculature.
Cockcroft JR; Chowienczyk PJ; Brett SE; Mant TG; Durnin C; Lynn F; Stevenson P; Ritter JM
Br J Clin Pharmacol; 1995 Dec; 40(6):591-3. PubMed ID: 8703667
[TBL] [Abstract][Full Text] [Related]
2. Effect of the non peptide angiotensin II antagonist, GR117289C on the vasoconstrictor actions of angiotensin II in the human forearm.
Lyons D; Webster J; Nixon A; Young MM; Smith J; Benjamin N
Br J Clin Pharmacol; 1997 Mar; 43(3):323-6. PubMed ID: 9088589
[TBL] [Abstract][Full Text] [Related]
3. Effects of losartan on vasoconstrictor responses to angiotensin II in the forearm vascular bed of healthy volunteers.
Baan J; Chang PC; Vermeij P; Pfaffendorf M; van Zwieten PA
Cardiovasc Res; 1996 Nov; 32(5):973-9. PubMed ID: 8944829
[TBL] [Abstract][Full Text] [Related]
4. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
Cockcroft JR; Sciberras DG; Goldberg MR; Ritter JM
J Cardiovasc Pharmacol; 1993 Oct; 22(4):579-84. PubMed ID: 7505360
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
Ritter JM; Cockcroft JR; Sciberras DG; Goldberg MR
J Hypertens Suppl; 1993 Apr; 11(3):S59-61. PubMed ID: 8391072
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man.
Ueda S; Masumori-Maemoto S; Ashino K; Nagahara T; Gotoh E; Umemura S; Ishii M
Hypertension; 2000 Apr; 35(4):998-1001. PubMed ID: 10775575
[TBL] [Abstract][Full Text] [Related]
8. Statin therapy increases vascular sensitivity to angiotensin II in hypercholesterolaemic patients.
Sim JS; Dick JB; Struthers AD
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):109-13. PubMed ID: 15526245
[TBL] [Abstract][Full Text] [Related]
9. Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)- receptors.
Phoon S; Howes LG
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):36-9. PubMed ID: 11984746
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the inhibitory effects of DuP 753 and EXP 3174 on responses to angiotensin II in the feline hindquarters vascular bed.
Osei SY; Minkes RK; Bellan JA; Kadowitz PJ
J Pharmacol Exp Ther; 1993 Mar; 264(3):1104-12. PubMed ID: 8450454
[TBL] [Abstract][Full Text] [Related]
11. Selective AT1 receptor antagonism enhances sympathetically mediated vasoconstriction in man.
Lyons D; Jackson SH; Swift CG
Clin Pharmacol Ther; 2007 Jan; 81(1):83-7. PubMed ID: 17186003
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist.
Cockcroft JR; Chowienczyk PJ; Brett SE; Bender N; Ritter JM
Br J Clin Pharmacol; 1994 Oct; 38(4):317-21. PubMed ID: 7833220
[TBL] [Abstract][Full Text] [Related]
13. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
Wong PC; Price WA; Chiu AT; Duncia JV; Carini DJ; Wexler RR; Johnson AL; Timmermans PB
J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
[TBL] [Abstract][Full Text] [Related]
14. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance.
Abernethy DR; Laurie N; Andrawis NS
Clin Pharmacol Ther; 1995 Sep; 58(3):328-34. PubMed ID: 7554707
[TBL] [Abstract][Full Text] [Related]
15. Urotensin II evokes potent vasoconstriction in humans in vivo.
Böhm F; Pernow J
Br J Pharmacol; 2002 Jan; 135(1):25-7. PubMed ID: 11786476
[TBL] [Abstract][Full Text] [Related]
16. Aging is associated with endothelial dysfunction in the human forearm vasculature.
Andrawis N; Jones DS; Abernethy DR
J Am Geriatr Soc; 2000 Feb; 48(2):193-8. PubMed ID: 10682949
[TBL] [Abstract][Full Text] [Related]
17. The effects of candesartan on vascular responses to angiotensin II and norepinephrine in normal volunteers.
Tran D; Phoon S; Howes L
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):199-203. PubMed ID: 11881123
[TBL] [Abstract][Full Text] [Related]
18. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibition does not affect the response to exogenous angiotensin II in the human forearm.
Lyons D; Stewart D; Webster J; Benjamin N
Br J Clin Pharmacol; 1994 Nov; 38(5):417-20. PubMed ID: 7893582
[TBL] [Abstract][Full Text] [Related]
20. Repeatability of local forearm vasoconstriction to endothelin-1 measured by venous occlusion plethysmography.
Strachan FE; Newby DE; Sciberras DG; McCrea JB; Goldberg MR; Webb DJ
Br J Clin Pharmacol; 2002 Oct; 54(4):386-94. PubMed ID: 12392586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
